MainboardGMP
LIVE
LIVE GMP
Watrana Rentals Ltd₹0·Crystal Crop Protection Ltd₹+45·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·M.K.Sons Fine Jewels Ltd₹+3·Watrana Rentals Ltd₹0·Crystal Crop Protection Ltd₹+45·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·M.K.Sons Fine Jewels Ltd₹+3·
Home › IPOs › Claris Lifesciences Ltd.
CL
Claris Lifesciences Ltd.
CLOSED NSE & BSE Bookbuilding IPO Fresh Capital Claris Lifesciences IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹235
Issue Price: ₹ 235
Issue Price
₹235
Face Value
₹10
Lot Size
22 shares
Open Date
24 Nov 2010
Close Date
02 Dec 2010
Listing Date
20 Dec 2010
Exchange
NSE & BSE
Claris Lifesciences IPO About the Company

Incorporated in 1994, Claris Lifesciences Limited (CLL) is an Ahmedabad based pharmaceutical company. Claris is the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Claris offers 113 products across multiple markets and therapeutic areas. All of these products are off-patent products.

Claris's product range across various therapeutic segments, including anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral nutrition, parenteral nutrition and oncology.

Companies more than half of the sales come from international markets and have a strong presence in regions of Latin America, the Middle East, Africa and Central, South East and Far East Asia.

Claris's manufacturing facilities are located in Ahmedabad, India and approved by foreign regulatory authorities. The manufacturing facilities are ISO 9001-2000 and WHO GMP certified.

...read more
Claris Lifesciences IPO Objects of the Issue
Purpose Amount (₹ Cr)
1 Setting up of a new plant comprising a small volume parenterals line, a PVC bag line, a non-PVC bag line and a fat emulsion line. ₹132
2 Setting up of a new manufacturing line for propofol and other fat emulsion products at the existing plant, Clarion IV. ₹26
3 Construction of a facility for research and development at the Clarion manufacturing facilities. ₹38
4 Prepayment of an identified term loan. ₹46
5 General corporate purposes. ₹32
Claris Lifesciences IPO Lead Managers
Edelweiss Financial Services Ltd Axis Capital Ltd. ICICI Securities Ltd. JM Financial Ltd.
Financial Summary Amount in ₹ Crore
Metric 31-Dec-09 31-Dec-08 31-Dec-07
Revenue 759 764 624
PAT 130 108 83
Claris Lifesciences IPO Key Financial Ratios
RONW
24
Issue Details
Total Shares Offered
12,632,477 (100%)
Pre-Issue Shareholding
51,185,288 shares
Post-Issue Shareholding
63,817,765 shares
UPI Mandate
02 Dec 2010
IPO Analytics Dashboard
LIVE
Claris Lifesciences IPO GMP Insights
👤
Retail Demand
Good
💼
HNI Interest
Good
🏦
QIB Demand
Strong
📊
Valuation
Moderate
Claris Lifesciences IPO GMP Strength Score
7 / 10 Good
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Claris Lifesciences IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
🏦 QIB — 7,579,487 (60%) —
💼 NII / HNI — 1,263,247 (10%) —
👤 Retail (RII) — 3,789,743 (30%) —
Σ Total — 12,632,477 (100%) —

* Amount calculated at upper price band (₹235) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
🏦
QIB ? 7,579,487 (60%)
60%
💼
NII / HNI ? 1,263,247 (10%)
10%
👤
Retail (RII) ? 3,789,743 (30%)
30%
Total Shares Offered 12,632,477 (100%)
Claris Lifesciences IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 22
Min. Investment ₹5,016
💼 HNI Investors ?
Min. Lots 40
Min. Shares 880
Min. Investment ₹200,640
🏛️ bHNI (>₹10L) ?
Min. Lots 200
Min. Shares 4,400
Min. Investment ₹1,003,200
Investor Interpretation
  • Retail allocation is good at 30% of the total offering.
  • HNI/NII demand is good at 10%.
  • Institutional (QIB) interest is strong at 60%.

This IPO shows moderate investor interest. Review financial details and compare valuation with industry peers before investing.

STOCK PRICE HISTORY  ·  NSE
—
Issue Price: ₹ 235  ·  Symbol: —
H —
L —
O —
Claris Lifesciences IPO Company Info
📍 Claris Corporate Headquarters, Near Parimal Railway Crossing, Ellisbridge Ahmedabad, Gujarat, 380006
Visit Website
Claris Lifesciences IPO Registrar
MUFG Intime India Pvt.Ltd.
Check Allotment Status
Claris Lifesciences IPO FAQs
Claris Lifesciences IPO has already listed. Its last recorded GMP was ₹0. GMP is only indicative and never a guarantee of listing gains.
The issue price of Claris Lifesciences IPO is ₹235 per share. One lot has 22 shares, so the minimum investment is about ₹5,170. It is a Fresh Capital issue.
Claris Lifesciences IPO opened on 24 Nov 2010 and closed on 02 Dec 2010. Shares are listed on NSE & BSE on 20 Dec 2010.
Incorporated in 1994, Claris Lifesciences Limited (CLL) is an Ahmedabad based pharmaceutical company. Claris is the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide.
As per the offer document, Claris Lifesciences plans to use the IPO proceeds for: 1 Setting up of a new plant comprising a small volume parenterals line, a PVC bag line, a non-PVC bag line and a fat emulsion line. (₹132); 2 Setting up of a new manufacturing line for propofol and other fat emulsion products at the existing plant, Clarion IV. (₹26); 3 Construction of a facility for research and development at the Clarion manufacturing facilities. (₹38); 4 Prepayment of an identified term loan. (₹46); 5 General corporate purposes. (₹32).
The lead managers of Claris Lifesciences IPO are Edelweiss Financial Services Ltd, Axis Capital Ltd., ICICI Securities Ltd., JM Financial Ltd..
Claris Lifesciences IPO is proposed to list on NSE & BSE; it is a Bookbuilding IPO and the issue is a Fresh Capital.
Disclaimer

The information on mainboardgmp.com is provided for educational and informational purposes only.

We are not a Securities and Exchange Board of India (SEBI)-registered investment advisor, analyst, broker, or financial planner. The content, data, and insights on this website, including Grey Market Premium (GMP), subscription data, IPO dates, and market information, are not intended as financial advice or recommendations to buy, sell, or hold securities.

GMP and related IPO data are collected from unofficial market sources and may not reflect actual IPO listing performance or future price movements. You should not rely solely on the information provided here to make financial or investment decisions.

Investing in IPOs and securities involves risk. Always conduct your own research and consult a qualified SEBI-registered financial advisor before making investment decisions. mainboardgmp.com and its owners shall not be liable for any financial losses, trading losses, or damages arising from use of this website.

By using this website, you acknowledge and agree that you use the content at your own risk.